The conceptual study of Nidan & Deha Prakriti in relation to Tamaka Shwasa w.s.r. to Bronchial Asthma and its management with Pushkarmula (Inula racemosa Hook. f. ) in comparison to Somlata (Ephedra gerardiana Wall
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To compare the effects of Pushkarmula and Somlata in reducing asthma symptoms (Tamaka Shwasa).
研究概览
简要总结
This study explores the concept of Nidan (causative factors) and Deha Prakriti (body constitution) in relation to Tamaka Shwasa (Bronchial Asthma) through an Ayurvedic perspective. Tamaka Shwasa, a chronic respiratory disorder, is influenced by various dietary, lifestyle, and environmental factors, along with an individual’s Prakriti, which determines their susceptibility to the disease.
The research aims to compare the efficacy of two Ayurvedic herbs—Pushkarmula (Inula racemosa) and Somlata (Ephedra gerardiana)—in the management of Tamaka Shwasa. While Pushkarmula is known for its anti-inflammatory and bronchodilator properties, Somlata is traditionally used for its rapid asthma-relieving effects. The study evaluates their impact on symptom relief, lung function, and overall quality of life, while also analyzing how different Prakriti types respond to these treatments.
By correlating Nidan and Prakriti with disease manifestation and management, this research aims to provide insights into personalized Ayurvedic treatment approaches for Bronchial Asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients fulfilling the diagnostic criteria.
- •Patients willing to participate in the trial.
- •Patient in the age group between 16–70 years
- •Patients with mild to moderate presentation in symptoms.
排除标准
- •Patients not willing for the clinical trial.
- •Patients below 16 years and above 70 years of age.
- •Patients suffering from jaundice , anaemia ,hepatitis ,chronic renal disorders , chronic infectious and Other serious disease Pregnant ladies and lactating mothers.
- •Patients suffering from diseases like other chronic respiratory like status asthmaticus, cardiac, hepatic and hormonal disease Any other condition which the principal investigator thinks may jeopardize the study.
结局指标
主要结局
To compare the effects of Pushkarmula and Somlata in reducing asthma symptoms (Tamaka Shwasa).
时间窗: Day 0: Baseline assessment, Prakriti analysis, start treatment. | Day 14: First follow-up, symptom check, side effects. | Day 28: Second follow-up, reassess symptoms and progress. | Day 42: Third follow-up, monitor changes. | Day 56: Final evaluation, compare outcomes, end of study.
To observe improvement in breathing problems, such as wheezing, coughing, and shortness of breath.
时间窗: Day 0: Baseline assessment, Prakriti analysis, start treatment. | Day 14: First follow-up, symptom check, side effects. | Day 28: Second follow-up, reassess symptoms and progress. | Day 42: Third follow-up, monitor changes. | Day 56: Final evaluation, compare outcomes, end of study.
To study how different body types (Deha Prakriti) influence asthma and its treatment.
时间窗: Day 0: Baseline assessment, Prakriti analysis, start treatment. | Day 14: First follow-up, symptom check, side effects. | Day 28: Second follow-up, reassess symptoms and progress. | Day 42: Third follow-up, monitor changes. | Day 56: Final evaluation, compare outcomes, end of study.
To identify common causes (Nidan) that trigger or worsen asthma in patients
时间窗: Day 0: Baseline assessment, Prakriti analysis, start treatment. | Day 14: First follow-up, symptom check, side effects. | Day 28: Second follow-up, reassess symptoms and progress. | Day 42: Third follow-up, monitor changes. | Day 56: Final evaluation, compare outcomes, end of study.
次要结局
- The secondary outcome of this study includes assessing the long-term sustainability of symptom relief, impact on quality of life, and changes in Prakriti-based response patterns. It also evaluates the safety profile of Pushkarmula and Somlata, reduction in the use of conventional medications, and influence on Nidan (causative factors) in disease progression.(The secondary outcome assessment will be conducted at key time points:)
研究者
Dr Akhilesh Kumar Srivastava
Rajiv Gandhi Government Post Graduate Ayurvedic College And Hospital